Philip Manger, MD
Otolaryngology · Baxter, MNNPI 1699709089
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,411 of the $1,826 with a category attached, or 77.3%. 9 manufacturers reported payments, led by Acclarent, Inc at 47.7% of the total. Reporting peaked in 2019 at $935 and has fallen 95.8% since, to $39 in 2025.
Across 39 payments — averaging $46.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$871
- Medical Device Business Services, Inc.$414
- Aerin Medical Inc.$175
- Preceptis Medical, Inc.$138
- Intersect ENT, Inc.$122
- Stryker$51
- plus $54 from 3 others
What the payments were for
- Travel & lodging$41423%
- Food & beverage$1,41177%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 23 | $871 |
| Medical Device Business Services, Inc. | 1 | $414 |
| Aerin Medical Inc. | 4 | $175 |
| Preceptis Medical, Inc. | 2 | $138 |
| Intersect ENT, Inc. | 4 | $122 |
| Stryker | 2 | $51 |
| Integra Lifesciences Corporation | 1 | $22 |
| Smith+Nephew | 1 | $20 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,826 in reported general payments places this provider in the 75th percentile of 181 otolaryngology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 172 | $5,925 |
| Azelastine Hcl | 155 | $3,465 |
| Mometasone Furoate | 26 | $1,784 |
| Fluocinolone Acetonide Oil | 29 | $1,267 |
| Omeprazole | 48 | $901 |
| Cefdinir | 17 | $441 |
| Fluticasone Propionate | 24 | $362 |
| Ofloxacin | 12 | $283 |
| Clindamycin Hcl | 15 | $256 |
| Mupirocin | 36 | $254 |
| Pantoprazole Sodium | 23 | $201 |
| Cephalexin | 21 | $179 |
| Methylprednisolone | 27 | $156 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $74 |
| Azithromycin | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Baxter
- Kurtis WatersBaxter$6K
- Samuel LevineMinneapolis$151K
- George GodingMinneapolis$143K
- Theodore TruittSaint Cloud$96K
- Matthew CarlsonRochester$80K
- Troy HemmeMaple Grove$28K
- Michael PaparellaMinneapolis$22K
- Oleg FroymovichMinneapolis$20K
- David HamlarSt. Paul$19K
- Rijul KshirsagarRochester$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.